Agilent Leverages NVIDIA and AWS Technology to Improve Analysis Speeds of Genomics Bioinformatics Pipelines

Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data

Excerpt from the Press Release:

Agilent Technologies Inc. (NYSE: A), a global leader in genomics technology, today announced it will use Amazon Elastic Compute Cloud (Amazon EC2) G5g instances powered by Amazon Web Services (AWS) Graviton2 processors and featuring NVIDIA T4G Tensor Core GPUs, in combination with NVIDIA Clara Parabricks’ advanced genomics analysis capabilities, to significantly improve processing speeds for variant calling workflows on Agilent’s cloud-native Alissa Reporter software.

This collaboration enables Agilent to offer streamlined workflow solutions for its SureSelect family of next-generation sequencing (NGS) assays comprising a wide range of custom and catalog panels, including SureSelect Human Exome reagents. The integration of NVIDIA Clara Parabricks platform with the Alissa secondary analysis pipelines enables clinical labs and researchers to benefit from fast panel-specific data analysis solutions in a secure and user-friendly cloud software environment.

“Agilent’s SureSelect panels are widely utilized to enrich samples for specific genes of interest, enabling cost-effective targeted sequencing. We’re now able to leverage our bioinformatics expertise, in combination with NVIDIA’s compute expertise, to offer our customers optimized analysis solutions through a combination of Agilent’s optimized variant calling algorithms and NVIDIA’s accelerated compute capabilities,” said Kevin Meldrum, Vice President and General Manager of Agilent’s Integrated Genomics Division.

Click the button below to read the entire Press Release:

Continue Reading The Press Release